Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > On la Presse

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Sep 13, 2024 5:30pm

96 Views

Post# 36223174

RE:On la Presse

It's good in the way it reinstates that the sales trend seem Ok for now. It's paid advertisement. What I dislike is the fact that our game changer th1902 is almost being downplayed here. Also they highlight the importance of IQ and the fact that they are the biggest shareholder now. Not exactly my friends for the 25 cents dilution. Anyway it's up today. My ACB is 16$ so I'll take a couple of them.

<< Previous

Bullboard Posts

Next >>

How to trade on the stock market: A beginner’s guide